News Daily News Year in Review: New Guidelines, Inclisiran, Dapagliflozin Impact CVD Prevention in 2019 Yael L. Maxwell December 20, 2019
News Features Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019 Todd Neale December 10, 2019
News Conference News AHA 2019 Apabetalone Falls Short in Diabetic ACS Patients With Low HDL: BETonMACE Yael L. Maxwell November 21, 2019
News Daily News FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl Michael O'Riordan November 14, 2019
News Daily News Lipid Levels Declining in US, With Drops Seen After 2013 Guideline Release Michael O'Riordan November 11, 2019
News Daily News New Review Questions Statin Benefit in Lower-Risk Primary Prevention Patients Michael O'Riordan October 22, 2019
News Conference News ESC 2019 New ESC Diabetes Guidelines Focus on CVD Prevention, New Drug Classes, and Low LDL Michael O'Riordan September 05, 2019
News Conference News EAS 2019 Bempedoic Acid/Ezetimibe Combo Lowers LDL Cholesterol in High-Risk Patients Michael O'Riordan May 30, 2019
News Conference News EAS 2019 CHD Mortality Significantly Elevated in Patients With Severe FH Michael O'Riordan May 29, 2019
News Daily News EXCEL Insights: CABG Outcomes for Left Main CAD Have Improved Substantially Michael O'Riordan April 22, 2019
News Daily News Younger Type 2 Diabetes Patients Face Higher Mortality and CVD Risks Michael O'Riordan April 10, 2019
News Daily News Color-Coded Cues and Physician Prompts Boost Evidence-Based Therapy in High-Risk CVD L.A. McKeown April 03, 2019
News Daily News Many Statin-Eligible Patients Don’t Take Meds, and Say Doctor Is to Blame Michael O'Riordan March 27, 2019
News Conference News ACC 2019 New DECLARE-TIMI 58 Data Shine a Light on Diabetes Patients Most Likely to Benefit From Dapagliflozin Shelley Wood March 26, 2019
News Conference News ACC 2019 Modest LDL Cholesterol Reduction With Bempedoic Acid in Among High-Risk Patients: CLEAR Wisdom Michael O'Riordan March 20, 2019